Last updated: February 20, 2026
What Is the Scope of Patent AR116001?
Patent AR116001 was granted in Argentina for a pharmaceutical invention. Its scope covers specific formulations, methods of use, and potentially the manufacturing process for a drug. The patent aims to protect the invention against unauthorized manufacturing, use, and sale within Argentina.
Key aspects include:
- Type of invention: The patent relates to a novel pharmaceutical compound or formulation, possibly a new dosage form or combination.
- Protection zone: It is territorial, limited to Argentina, but reflects knowledge of the patent landscape in Latin America.
- Protection term: As per Argentine law, patent protection lasts 20 years from the filing date, which must be verified for AR116001.
The patent’s scope is limited to what is explicitly claimed. Broad claims can cover multiple formulations or methods, while narrow claims focus on specific compound structures or processes.
What Are the Key Claims of AR116001?
An examination of the granted claims reveals the territorial and inventive boundaries. Although the full text of claims is necessary for comprehensive precision, typical patent claims include:
- Compound claims: Covering the chemical entity itself, characterized by specific molecular structures, substituents, or isomers.
- Use claims: Methods for treating specific diseases with the compound.
- Formulation claims: Specific pharmaceutical compositions, including excipients or carriers.
- Process claims: Methods for manufacturing the compound or formulation.
In general, Argentine patents must clearly define the invention and its novel features, avoiding overly broad claims to ensure enforceability.
Example Claim Breakdown (Hypothetical)
| Type of Claim |
Description |
Remarks |
| Compound |
A chemical compound with a specified molecular formula |
Likely includes specific stereochemistry or substitutions |
| Use |
Use of the compound to treat particular diseases |
May specify indications such as cancer, infections, etc. |
| Formulation |
A pharmaceutical composition comprising the compound and excipients |
Focuses on dosage form, stability, bioavailability |
| Method |
A process for synthesizing the compound |
Describes synthetic routes, reagents, and conditions |
What Is the Patent Landscape in Argentina for Similar Drugs?
Argentina’s patent landscape for pharmaceuticals, including innovative drugs, features:
- Patent eligibility: Focus on novelty, inventive step, and industrial applicability.
- Patent filing trends: An increasing number of filings for biotechnology and innovation-driven drugs since 2010.
- Major players: Multinational pharmaceutical companies (Pfizer, Novartis, Roche) dominate filings, with regional companies and universities contributing.
- Patent expiration: Patents for blockbuster drugs typically expire after 20 years, opening opportunities for generics.
- Compulsory licensing: The Argentine government can issue licenses in cases of health emergencies or public interest, which can impact patent enforceability.
In Latin America, pharmaceutical patenting faces unique challenges, including:
- Strict patentability criteria with emphasis on inventive step and patentable subject matter.
- Patent examination delays, often taking 2-4 years.
- Freedom-to-operate (FTO) landscape, including prior art from regional patents and publications.
How Does Patent AR116001 Fit Within the Broader Landscape?
- If the patent claims are broad, it might block development or commercialization of similar drugs in Argentina.
- Narrow claims limit scope but reduce risk of invalidation.
- The patent’s filing date determines its priority over later filings, influencing freedom to operate.
- The patent’s validity can be challenged through opposition procedures or invalidity claims, common in Latin America.
What Are the Legal and Commercial Implications?
- Patent enforcement: Argentina allows patent owners to initiate infringement suits. Enforcement can be costly and uncertain.
- Market exclusivity: Patent AR116001 provides at least 20 years of exclusivity, but patent life can be shortened by delays or legal challenges.
- Licensing and partnerships: Patents enable licensing agreements with local or international firms.
- Generic entry risk: Once the patent expires or is invalidated, generic manufacturers can enter the market.
Summary of Key Data
| Aspect |
Data / Observation |
| Patent filing date |
To verify against current legal status (not provided in user input) |
| Patent expiry |
20 years from filing (~2023+ based on filing date) |
| Claim scope |
Disease treatment, chemical structure, formulation, synthesis process |
| Patent landscape |
Growing filing activity in Latin America, multinational dominance, patent challenges |
| Enforcement |
Available via legal action; subject to commercial and legal costs |
Key Takeaways
- Patent AR116001 covers specific pharmaceutical compounds and formulations with territorial protection in Argentina.
- Claims encompass chemical compounds, uses, formulations, and synthesis methods, with scope depending on claim specificity.
- The patent landscape in Argentina favors innovations with clear novelty and inventive steps; patent filings from global companies are common.
- Enforcement involves legal proceedings, and patent risks include invalidation and competition from generics post-expiry.
FAQs
1. How long does patent AR116001 last in Argentina?
It lasts 20 years from the filing date, typically expiring around 2023 unless extensions apply.
2. Can the scope of AR116001 be challenged?
Yes, through invalidity procedures based on prior art or lack of novelty/inventive step.
3. Does the patent cover only the chemical compound?
No, claims likely include use, formulation, and synthesis methods.
4. How does the patent landscape influence drug development?
It indicates the level of innovation required and potential patent obstacles for similar drugs.
5. What are the risks of infringing patent AR116001?
Legal actions, damages, and injunctions can result if infringement is proven; careful FTO analysis is vital.
References
[1] Argentine Patent Law, Ley de Patentes, Law No. 24,481 (1998).
[2] World Intellectual Property Organization. (2022). Latin America Patent Trends.
[3] Patent Scope, World Intellectual Property Organization. (2022). Argentine Patent Data.
[4] European Patent Office. (2022). Patent Landscape Reports for Latin America.
[5] Latin American Patent Reports, IQVIA. (2022). Pharmaceutical Innovation Trends.
